Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1946 2
1947 1
1948 6
1949 7
1950 2
1951 3
1952 6
1953 5
1954 6
1955 8
1956 4
1957 11
1958 13
1959 19
1960 22
1961 29
1962 35
1963 54
1964 84
1965 106
1966 297
1967 503
1968 668
1969 704
1970 794
1971 900
1972 1095
1973 1170
1974 1210
1975 1192
1976 1081
1977 1108
1978 1047
1979 1081
1980 985
1981 929
1982 976
1983 982
1984 1005
1985 1011
1986 973
1987 826
1988 998
1989 998
1990 1098
1991 1120
1992 1205
1993 1191
1994 1200
1995 1243
1996 1227
1997 1265
1998 1260
1999 1309
2000 1484
2001 1622
2002 1661
2003 1727
2004 1790
2005 1907
2006 2075
2007 2069
2008 2260
2009 2399
2010 2427
2011 2587
2012 2669
2013 3059
2014 3022
2015 3024
2016 2794
2017 2668
2018 2444
2019 1115
2020 21
Text availability
Article attribute
Article type
Publication date

Search Results

74,414 results
Results by year
Filters applied: . Clear all
Page 1
Pharmacological lipid-modification therapies for prevention of ischaemic heart disease: current and future options
Ray KK, et al. Lancet 2019 - Review. PMID 31448741 Free article.
In addition to LDL cholesterol, mendelian randomisation studies support a causal role for lipoprotein(a) and triglycerides in ischaemic heart disease. In this Series paper, we appraise currently available and emerging therapies for lowering LDL cholesterol, lipoprotein(a), and triglycerides for prevention of ischaemic heart disease....
In addition to LDL cholesterol, mendelian randomisation studies support a causal role for lipoprotein(a) and triglycerides in ischaem …
Latest Updates on Lipid Management
Egom EE, et al. High Blood Press Cardiovasc Prev 2019 - Review. PMID 30877603
Serum triglycerides as a risk factor for cardiovascular diseases in type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies.
Ye X, et al. Cardiovasc Diabetol 2019. PMID 30987625 Free PMC article.
OBJECTIVE: The importance of triglycerides (TG) level as a risk factor for cardiovascular diseases (CVD) has been extensively investigated in the general population; however, their relationship in patients with type 2 diabetes mellitus (T2DM) is uncertain. ...CONCLUSIONS: In T2DM patients, an elevated triglyceride level cannot serve as an independent marker for an increased risk of cardiovascular events, but still, the higher serum TG levels tend to be associated with increased risks of CVD....
OBJECTIVE: The importance of triglycerides (TG) level as a risk factor for cardiovascular diseases (CVD) has been extensively investi …
Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome.
Witztum JL, et al. N Engl J Med 2019 - Clinical Trial. PMID 31390500
In an open-label study of three patients with this syndrome, antisense-mediated inhibition of hepatic APOC3 mRNA with volanesorsen led to decreased plasma apolipoprotein C-III and triglyceride levels. ...CONCLUSIONS: Volanesorsen lowered triglyceride levels to less than 750 mg per deciliter in 77% of patients with familial chylomicronemia syndrome. ...
In an open-label study of three patients with this syndrome, antisense-mediated inhibition of hepatic APOC3 mRNA with volanesorsen led to de …
Effects of medium chain triglycerides on body fat distribution and adipocytokine levels in children with acute lymphoblastic leukemia under chemotherapy.
Zhang R, et al. Medicine (Baltimore) 2019 - Clinical Trial. PMID 31415396 Free PMC article.
The aim of the study was to investigate the effects of high-proportion medium chain triglyceride (MCT) on body fat distribution and levels of leptin and adiponectin during chemotherapy of children with ALL.New-onset ALL children treated at the Guangzhou Women and Children's Medical Center between March 2016 and March 2017 were enrolled. ...
The aim of the study was to investigate the effects of high-proportion medium chain triglyceride (MCT) on body fat distribution and l …
HDL Triglycerides: A New Marker of Metabolic and Cardiovascular Risk.
Girona J, et al. Int J Mol Sci 2019. PMID 31252694 Free PMC article.
While cholesterol content in high-density lipoproteins (HDLs) is a well-established inverse marker of cardiovascular risk, the importance of HDL-triglyceride (HDL-TG) concentration is not well known. ...HDL-TG was associated with all triglyceride-rich lipoprotein parameters and had an opposite association with HDL-C and HDL-P. ...
While cholesterol content in high-density lipoproteins (HDLs) is a well-established inverse marker of cardiovascular risk, the importance of …
Lipid levels and the risk of hemorrhagic stroke among women
Rist PM, et al. Neurology 2019. PMID 30971484 Free PMC article.
Women in the lowest quartile of triglycerides had a significantly increased risk of hemorrhagic stroke compared to women in the top quartile after multivariable adjustment (RR 2.00; 95% CI 1.18, 3.39). ...CONCLUSION: LDL-C levels <70 mg/dL and low triglyceride levels were associated with increased risk of hemorrhagic stroke among women....
Women in the lowest quartile of triglycerides had a significantly increased risk of hemorrhagic stroke compared to women in the top q …
74,414 results
Jump to page
Feedback